
Viltas DM 1000mg/50mg Tablet SR
Marketer
Tas Med India Pvt Ltd
Salt Composition
Metformin (1000mg) + Vildagliptin (50mg)
Overview Viltas DM 1000mg/50mg Tablet SR
DiabetiCare Duo 1000mg/50mg Extended-Release Tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like nephropathy and vision impairment, potentially lowering the risk of cardiovascular events. DiabetiCare Duo may be prescribed independently or in conjunction with other antidiabetic therapies. Optimal efficacy is achieved through adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glycemic control, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Effective blood sugar regulation and the prevention of future complications are key goals. Maintaining the prescribed diet and exercise regime is crucial for overall diabetes management; lifestyle choices significantly influence glycemic control. Commonly reported side effects encompass diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia, a potential adverse effect when used with insulin or sulfonylureas, necessitates familiarity with its recognition and management. This medication isn't universally suitable. Prior to initiation, disclose any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption to your physician. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate comprehensive disclosure of all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its potential for hypoglycemia. Regular monitoring of renal function and blood glucose levels will be performed by your doctor throughout treatment.
Primary Ingredients of Viltas DM 1000mg/50mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Viltas DM 1000mg/50mg Tablet SR
Managing type 2 diabetes
Major Benefits of Viltas DM 1000mg/50mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Viltas DM 1000mg/50mg Extended-Release tablets with food.
Common Side effects of Viltas DM 1000mg/50mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Trembling
- Headache
- Dizziness
- Nausea
- Weakness
- Gastro-esophageal reflux disease
- Increased sweating
- Decreased appetite
How to use Viltas DM 1000mg/50mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; do not break, chew, or crush it. The Viltas DM 1000mg/50mg sustained-release tablet should be taken with a meal.
How Viltas DM 1000mg/50mg Tablet SR works:
Each Viltas DM SR tablet (1000mg/50mg) combines two distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Viltas DM 1000mg/50mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Viltas DM 1000mg/50mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Viltas DM 1000mg/50mg sustained-release tablets while breastfeeding is likely inadvisable. Scant human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Viltas DM 1000mg/50mg Tablet SR to individuals with impaired renal function. Dosage modification of Viltas DM 1000mg/50mg Tablet SR might be necessary. Physician consultation is recommended.
LiverUNSAFE
The extended-release Viltas DM 1000mg/50mg tablet may pose significant risks for individuals with hepatic impairment and its use should be avoided. Medical advice is recommended.
What if you forget to take Viltas DM 1000mg/50mg Tablet SR :
Should you forget to take a Viltas DM 1000mg/50mg sustained-release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Viltas DM 1000mg/50mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Treatment |
